Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2013.09.26
重大事项停牌公告
2013.09.14
2013年第一次临时股东大会的法律意见书
2013.09.14
2013年第一次临时股东大会决议公告
2013.09.14
关于公司高级管理人员辞职的公告
2013.08.29
第二届监事会第二十四次会议决议公告
2013.08.29
2013年半度募集资金存放与使用情况的专项报告
2013.08.29
关于调整2013年度部分日常关联交易预计的公告
2013.08.29
关于召开2013年第一次临时股东大会的通知公告
2013.08.29
关于向银行申请专项授信额度的公告
2013.08.29
关于变更会计师事务所的公告
第一页
上一页
124
125
126
127
128
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
